Journal: Chemical Engineering Journal
Article Title: Extracellular vesicles from mechanical loading stimulated-macrophages favor fracture healing through targeting Adrb2 of osteoblasts
doi: 10.1016/j.cej.2024.159079
Figure Lengend Snippet: Fig. 7. Adrb2 of osteoblasts could be a target of bone repair. A) Schematic diagram of putative binding sites in the Adrb2-3′UTR and quantitative analysis of relative luciferase activity of recipient cells after mutating (MUT) the binding site of 3′-UTR-driven reporters (n = 4). B) Quantitative analysis of mRNA expression of Adrb2 in MC3T3-E1 cells transfected with mimic-NC, mimic-let-7 g-5p, inhibitor-NC, inhibitor-let-7 g-5p. The expression of Gapdh serves as the loading control (n = 4). C) Quantitative analysis of protein levels of ADRB2 in MC3T3-E1 cells transfected with mimic-NC, mimic-let-7 g-5p, inhibitor-NC, inhibitor-let-7 g-5p. The expression of GAPDH serves as the loading control (n = 4). D, E) Representative μCT images of fractured femurs and quantitative analysis of callus from 12-week male Adrb2WT and Adrb2Δ OCN male mice treated with NC– antagomir or let-7 g-5p antagomir on 14th day post-fracture (n = 6). F, G) Representative images of HE and SO/FG staining in the fractured site from 12-week Adrb2WT and Adrb2Δ OCN male mice. Scale bar: 500 μ m. H, I) Representative images of IHC staining and quantitate analysis of RUNX2 and OCN expression in the callus from 12-week male Adrb2WT and Adrb2Δ OCN male mice on 14th day post-fracture (n = 5). Scale bar: 50 μm. An individual sample was represented by a dot plot, and data are presented as means ± standard deviation (SD). *p < 0.05, **p < 0.01 and ***p < 0.001, ns: not significant. Statistical significance was determined by two-tailed Student’s t-test (A), one-way ANOVA (B and C), or two-way ANOVA (E to I).
Article Snippet: The antibodies were as follows: RUNX2 (Abcam, ab192256; 1:1000), OCN (Takara, M188, 1:150), F4/80 (Invitrogen, 14–4801-82; 1:100), PIEZO1 (Proteintech, 15939–1-AP; 1:400), CD63 (Abcam, ab217345; 1:100), CD31 (R&D Systems, AF3628; 1:100) and Endomucin (Santa Cruz, sc-65495; 1:100), Ki67 (Abcam, ab15580; 1:1000), ADRB2 (Abcam, ab182136; 1:100).
Techniques: Binding Assay, Luciferase, Activity Assay, Expressing, Transfection, Control, Staining, Immunohistochemistry, Standard Deviation, Two Tailed Test